Trump Administration, Through HHS, DoD, Purchases Additional 100M Doses Of Moderna’s COVID-19 Vaccine Candidate

HHS: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna
“The Trump administration, through the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD), will purchase an additional 100 million doses of COVID-19 vaccine candidate, called mRNA-1273, from Moderna. If authorized by the U.S. Food and Drug Administration for emergency use as outlined in agency guidance, doses of the vaccine will begin shipping immediately. … Under the agreement, Moderna will leverage its U.S.-based manufacturing capacity to fill, finish, and ship vials of mRNA-1273 as the bulk material is produced. The additional doses ordered … provide for continuous delivery through the end of June 2021…” (12/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.